polygenic risk score
Genomic Data Analytics Firm Galatea Bio Raises $25M
The company intends to use the funds to help expand its genomic database of people of non-European ancestry.
Can.Heal has produced a dozen reports that will inform both EU policies and national health strategies for personalized cancer treatment and prevention going forward.
Data from Myriad Genetics offered early validation evidence for an expanded version of its commercial test, as well as a look into clinical impact via claims data.
Biobanks have been making strides in gathering data from more diverse populations this year while the evidence for the clinical utility of embryo PRS testing remains insufficient.
Southern Research, MyOme, and Broad Clinical Labs will use $25 million in grants to provide genetic testing and counselling to up to 30,000 state residents.